A Revolution in Type 2 Diabetes Treatment

For most of the history of type 2 diabetes treatment, the therapeutic goal was glycemic control — managing blood glucose to prevent complications rather than addressing the underlying metabolic dysfunction driving the disease. GLP-1 receptor agonists — particularly semaglutide (Ozempic) and tirzepatide (Mounjaro) — have fundamentally changed this paradigm. These medications achieve glycemic control not as an endpoint but as a consequence of addressing the metabolic root: insulin resistance, excess body weight (particularly visceral fat), and beta cell exhaustion.

The Connection Between Obesity, Insulin Resistance, and Type 2 Diabetes

Type 2 diabetes is not primarily a pancreatic disease — it is a metabolic disease in which the pancreas eventually fails under the demand created by insulin resistance. Visceral fat (fat surrounding the abdominal organs) secretes inflammatory adipokines that block insulin receptor signaling in muscle, liver, and fat cells. The pancreas responds by increasing insulin production — maintaining blood glucose initially, but over years, the beta cells exhaust from chronic overproduction, and glucose control deteriorates.

Want to talk it through with our team?

Book a free 15-minute video consult. Start for $247 — includes your first doctor visit. No membership.

How it works, step by step · See medication prices

This pathophysiology means that reducing visceral fat and improving insulin sensitivity is the most direct way to reverse or halt type 2 diabetes progression — not merely treating its downstream glucose manifestations.

What GLP-1 Medications Do in Type 2 Diabetes

In type 2 diabetes specifically, GLP-1 receptor agonists produce several simultaneous metabolic benefits beyond appetite suppression and weight loss:

Is Type 2 Diabetes Reversible?

The DiRECT trial demonstrated that significant weight loss (15+ kg) through intensive lifestyle intervention produced remission of type 2 diabetes (HbA1c below 6.5% without medications) in approximately 50% of participants at one year. GLP-1/GIP dual agonists, which produce even greater weight loss than the DiRECT intervention in many patients, have produced type 2 diabetes remission in substantial proportions of patients in clinical data — making the concept of diabetes “reversal” through metabolic treatment a realistic clinical goal rather than an aspiration.

Managing Type 2 Diabetes at Multigen Wellness

Multigen Wellness providers manage type 2 diabetes as a metabolic and hormonal condition — addressing not just glucose but the full hormonal environment: testosterone (low testosterone worsens insulin resistance), thyroid function, cortisol dynamics, and body composition. This comprehensive approach produces outcomes that focus on glucose alone cannot achieve.

If you have type 2 diabetes and are ready to pursue metabolic reversal rather than just management, call Multigen Wellness at (800) 259-0015.

How it works

From your first call to medication at your door.

  1. A
    Free 15-minute video consult. We go over your goals, answer your questions, and confirm we can treat you in your state.
  2. B
    Start for $247, which includes your first doctor visit.
  3. C
    Lab work: free with insurance at Quest or any other lab. Book your Quest visit in your patient portal, or take our lab order form to any lab that takes your insurance.
  4. D
    Doctor visit: once results are back, meet by video with a dedicated hormone therapy specialist (PAs, NPs and doctors on staff) to review labs and plan medication or therapy.
  5. E
    Medication shipped to your door. We bill you for the medication and ship it to your house. See medication prices

What it costs

  • No monthly fee, no membership, no commitment.
  • $97 per visit, only when needed.
  • Prescriptions need lab work and a video visit at least every 90 days.
  • Most new patients are seen every 30 days at first.

See the full How It Works page

📞 1-800-259-0015 Sign Up Book Free Consult Patient Portal